Mereo Biopharma Group is down a bit on the day, funds flowing out kept the price down -2.68% since yesterday.
The company isn't at an immediate support or resistance level that might be predictive. Mereo Biopharma Group hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. MREO might find some support at the 0.292 level, buyers might push the price back up from here. But it's not very clear what will happen.